Denali Therapeutics Inc.

DNLI·NASDAQ·$19.38Share Price as of 11/2·$3BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/11/25

Disclosures

8-KCurrent report08/06/26 8-KCurrent report07/28/26 8-KCurrent report06/18/26 8-KCurrent report06/04/26 8-KCurrent report05/22/26

Prospectuses and Registrations

S-8Registration of securities for employees02/26/26 424B5Prospectus supplement12/10/25 424B5Prospectus supplement12/09/25 S-3ASRAutomatic shelf registration02/27/25 S-8Registration of securities for employees02/27/25

Proxies

DEF 14ADefinitive proxy04/21/26 DEFA14AAdditional proxy materials04/21/26 DEF 14ADefinitive proxy04/17/25 DEFA14AAdditional proxy materials04/17/25 DEF 14ADefinitive proxy04/18/24

Ownership

Form 4Insider transaction09/09/26 144Proposed sale of securities09/04/26 Form 4Insider transaction09/04/26 Form 4Insider transaction09/03/26 144Proposed sale of securities09/02/26

Other

ARSAnnual report to shareholders04/21/26 ARSAnnual report to shareholders04/17/25 ARSAnnual report to shareholders04/18/24 DD03/01/24 ARSAnnual report to shareholders04/18/23